IMMX
Immix Biopharma, Inc.
+0.60 (+5.03%)12.52USD409K成交股數896M市值–本益比(近四季)–股價營收比–營收年增(近四季)2026-11-06下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | – | – | – | – | – | – | – | – | – | – | – | – |
| 營業成本 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 研發費用 | 5.3M | 6.0M | 5.7M | 4.6M | 4.0M | 2.0M | 4.4M | 2.2M | 3.2M | 3.1M | 2.1M | 2.2M |
| 銷售管理費用 | 7.1M | 4.8M | 5.2M | 3.1M | 2.7M | 2.7M | 2.9M | 2.5M | 2.3M | 2.3M | 2.4M | 1.5M |
| 營業利益 | −12.5M+85% | −10.8M+131% | −10.9M+47% | −7.7M+63% | −6.7M+20% | −4.7M-13% | −7.4M+63% | −4.7M+26% | −5.6M | −5.4M | −4.5M | −3.7M |
| 營業利益率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 稅後淨利 | −11.6M+75% | −10.1M+122% | −10.6M+49% | −7.6M+73% | −6.6M+26% | −4.5M-11% | −7.1M+67% | −4.4M+23% | −5.3M | −5.1M | −4.3M | −3.6M |
| 淨利率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 稀釋 EPS | -0.18-18% | -0.18+20% | -0.28+17% | -0.24+60% | -0.220% | -0.15-38% | -0.24+4% | -0.15-38% | -0.22 | -0.24 | -0.23 | -0.24 |
| 稀釋股數 | 63.8M | 55.4M | 33.0M | 31.9M | 30.0M | 29.7M | 29.4M | 28.8M | 23.4M | 17.3M | 18.6M | 15.0M |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 225M | 79.3M | 93.9M | 15.9M | 11.6M | 15.9M | 19.7M | 24.0M | 29.3M | 17.5M | 19.6M | 12.7M |
| 應收帳款 | – | – | – | – | – | – | – | – | – | – | – | – |
| 存貨 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總資產 | 239M | 95.8M | 105M | 20.1M | 15.6M | 19.9M | 25.1M | 28.8M | 34.3M | 19.9M | 22.5M | 15.6M |
| 有息負債 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總負債 | 10.2M | 11.5M | 11.0M | 11.8M | 11.0M | 10.3M | 7.6M | 4.9M | 6.7M | 3.7M | 2.8M | 2.4M |
| 股東權益 | 229M | 84.4M | 93.8M | 8.3M | 4.7M | 9.6M | 17.6M | 23.9M | 27.9M | 16.4M | 19.8M | 13.2M |
| 負債比 | 4.3% | 12.0% | 10.5% | 58.8% | 70.2% | 51.8% | 30.2% | 17.1% | 19.6% | 18.7% | 12.6% | 15.4% |
| 淨現金(現金 − 有息負債) | – | – | – | – | – | – | – | – | – | – | – | – |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | −9.8M+483% | – | – | – | −1.7M | – | – | −3.8M | – | – | – |
| 資本支出 | – | 32K | – | – | – | 68K | – | – | 302K | – | – | – |
| 自由現金流 | – | −9.9M+462% | – | – | – | −1.8M | – | – | −4.1M | – | – | – |
| 折舊攤銷 | – | – | – | – | – | – | – | – | – | – | – | – |
| 買回庫藏股 | – | – | – | – | – | – | – | – | – | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | – | – | – | – | – | – | – | – | – | – | – |
營收拆解
這家公司的 XBRL 沒有標分部、產品或地區營收。多半是單一業務,或只在 10-K 文字裡揭露。
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | – | – | −29.4M | –% | -0.89 | −24.7M |
| FY2024 | – | – | −21.6M | –% | -0.76 | −15.8M |
| FY2023 | – | – | −15.4M | –% | -0.89 | −11.4M |
| FY2022 | – | – | −8.2M | –% | -0.59 | – |
| FY2021 | – | – | −24.4M | –% | -6.64 | −1.6M |
| FY2020 | – | – | −1.1M | –% | -0.34 | – |